This news article, first published on Contract Pharma.com, outlines how ICON has been selected by BARDA to execute an anthrax vaccine clinical trial.
Related information
Press Release
ICON selected by BARDA to conduct anthrax vaccine clinical trial
Webpage
Infectious diseases and vaccines insights
Press Release
ICON wins Best CRO at the Vaccine Industry Excellence Awards for third time
Press Release
BARDA reselects ICON as preferred partner
Infographic